Just moving on to Slide 10. Here, we're highlighting the distribution model that we expect for the vaccine in the pandemic phase. We have a co-commercialization arrangement in place with Pfizer, as many of you know, and are really working very, very closely with them and with the governments for global distribution. Pfizer has developed a thermal shipper unit, which has GPS tracking, specifically for this vaccine, which is designed to keep the product at low temperatures for up to 10 days if stored at 15 to 25 degree Celsius without opening the shipper.
And if we do open it, then upon reicing several times we can extend to 15 days on reopening. Further, we have the ability for five days storage in a refrigerator at 2 to 8 degrees centigrade. So that gives us really some flexibility with respect to storage and distribution. And the distribution model will, of course, depend on the region.
|
Thread abonnieren
